Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Medtronic
Novartis
US Army
Cantor Fitzgerald
Harvard Business School
Cerilliant
QuintilesIMS
Boehringer Ingelheim

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,906,898

« Back to Dashboard

Which drugs does patent 8,906,898 protect, and when does it expire?


Patent 8,906,898 protects ZERBAXA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 8,906,898

Title:Solid forms of ceftolozane
Abstract: Novel solid forms of ceftolozane are described, as well as methods for the preparation and use of these solid forms.
Inventor(s): Hwang; You Seok (Windham, NH), Damour; Nicole Miller (Belmont, MA), Duong; Lisa (Lynn, MA), Jurkauskas; Valdas (Cambridge, MA), Moshos; Kristos Adrian (Belmont, MA), Mudur; Sanjay (Woburn, MA), Ovat; Asli (Maynard, MA), Terracciano; Joseph (Concord, MA), Woertink; Jason (Sudbury, MA)
Assignee: Calixa Therapeutics, Inc. (Lexington, MA)
Application Number:14/289,224
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Cubist Pharms Llc
ZERBAXA
ceftolozane sulfate; tazobactam sodium
POWDER;IV (INFUSION)206829-001Dec 19, 2014RXYesYes► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,906,898

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2014233633► Subscribe
Australia2016200570► Subscribe
European Patent Office3049079► Subscribe
Mexico2016003958► Subscribe
New Zealand631761► Subscribe
World Intellectual Property Organization (WIPO)2015048217► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Farmers Insurance
Johnson and Johnson
Cipla
Novartis
Covington
Daiichi Sankyo
Teva
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot